Results 171 to 180 of about 27,715,337 (381)

Clothiapine: highlights on pharmacological and clinical profile of an undervalued drug

open access: diamond, 2022
Calogero Crapanzano   +3 more
openalex   +1 more source

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

open access: yesScience Signaling, 2013
Jianjiong Gao   +12 more
semanticscholar   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

Hormonal therapy in cancer of the breast.VIII. The effect of dihydrotestosterone (Androstanolone) on clinical course and hormonal excretion [PDF]

open access: bronze, 1955
Albert Segaloff   +4 more
openalex   +1 more source

Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

open access: yesClinical Microbiology Reviews, 2015
S. Tong   +4 more
semanticscholar   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy